Jeffrey S. Farrow, Chief Financial Officer at Global Blood Therapeutics, Inc. (GBT), sold 15,208 shares at $75.00 ($1.1M) on 2020-07-13, disclosed to the SEC on 2020-07-15.
Open-market sale of $1.1M GBT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TARS | SELL | 2025-06-18 | $1.1M | — | Filing → |
| TARS | SELL | 2025-03-20 | $357K | — | Filing → |
| TARS | SELL | 2024-06-20 | $574K | — | Filing → |